Instead, treatment with the PDGFRβ inhibitor Ki11502 resulted in a clear reduction of the proliferation and G2 cell cycle arrest of CRC cells, effects that were shown to be the result of the additional inhibition of c-KIT and SRC by Ki11502. Here, KIT is linked to colorectal carcinoma.